GIT Drugs Flashcards

1
Q

Drugs whose mode of action is the reduction of intragastric acidity

A

Antacids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

New types of drugs that are now currently used as opposed to Antacids

A

H2 receptor antagonists and Proton pump inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List of regularly Used Antacids

A

Sodium Bicarbonate
Calcium Bicarbonate
MgOH and AlOH3
Simethicone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Can cause renal insuffciency, metabolic aklalosis and belching

A

Sodium Bicarbonate and Calcium Bicarbonate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Can cause Hypercalcemia

A

Calcium Bicarbonate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Does not cause belching and metabolic alkalosis when used together

A

MgOH2 and AlOH3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MgOH2 and AlOH3 should not be taken within 2 hours of doses of these drugs

A

Tetracycline
Fluoroquinolones
Itraconazole
Iron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Anti foaming agent that decreases the surface tension of gas bubbles causing them to combine into larger bubbles in the stomach that can be passed easily.

Does not reduce or prevent the formation of gas, it increases the rate at which it exits the body.

A

Simethicone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

“-tidines”-
H2 blockers
Work by competitive inihibition of histamine binding to H2 receptors.

A

H2 Receptor antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MOA of H2 receptor antagonists

A

Competitive inihibition of histamine binding to H2 receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Characteristics of H2 blockers

A

Effective in inhibiting nocturnal gastric acid secretion

Raises nocturnal and fasting intragastric pH to 4-5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Examples of H2 blockers

A

Cimetidine (Prototype)
Ranitidine
Famotidine
Nizatidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

H2 blocker that inhibits CYP450

A

Cimetidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

H2 Blocker that does not inhibit CYP450 and has little first pass effect (almost 100% bioavailabaility)

A

Nizatidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Uses of H2 blockers

A

GERD
PUD
Intermittent Non Ulcer Dyspepsia
Rebleeding from stress related Gastritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ADE of H2 blockers

A

Increased risk of nosocomial pneumonia

Mental status changes due to Cimetidine

17
Q

ADE of H2 blockers

A

Gynecomastia and impotence in males
Galactorrhea in females (Cimetidine)
Due to inhibtiion of DHT binding to androgen receptor.

18
Q

Which drug interferes with CYP450

A

Cimetidine

19
Q

H2 Blockers that has no CYP450 interactions

A

Famotidine and Nizatidine

20
Q

H2 blockers that inhibit 1st pass metabolism of ethanol

A

Cimetidine
Ranitidine
Nizatidine

21
Q

Mode of action of proton pump inhibitors

A

Irreversibly inactivate parietal cell H/K Atpase

22
Q

Common suffix of PPIs

A

“azoles” from substituted benzimidazoles

23
Q

Prototype PPI

A

Omeprazole

24
Q

Other PPI examples

A
Esomeprazole
Lansoprazole
Dexlansoprazole
Rabeprazole
Pantoprazole
25
Q

Active form of PPIs

A

Thiophilic Sulfonamide

26
Q

Type of linkage PPIs form

A

covalent disulfide linkage

27
Q

True or False

It is best to give PPIs on a full stomach

A

False

Give PPIs on empty stomach

28
Q

How many hours before meal to give PPIs?

A

1 hour before meal

29
Q

Clinical Uses of PPis

A
GERD
PUD
NSAID Ulcers
Non Ulcer Dyspepsia
Stress Related Mucosal Bleeding
Stress- Related Mucosal Blreeding
Gastrinoma and Hypersecretion
30
Q

First line Treatment for GERD

A

PPIs

31
Q

Best approach for treating PUD

A

Triple Therapy 10-14 day regimen of
Clarithromycin
Amoxicillin
PPI

32
Q

Adverse effects of PPIs

A

Minor decrease in B12 absorption
Increase in risk of nosocomial infections
Rebound hypegastrinemia

33
Q

Significant Drug interaction of PPIs

A

Decrease in activation of clopidogrel

Omperazole/ Esmeprazole